STOCK TITAN

LifeStance Health (LFST) director granted 17,746 RSUs, holdings rise to 89,174 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Palmer Eric P reported acquisition or exercise transactions in this Form 4 filing.

LifeStance Health Group, Inc. director Eric P. Palmer received an equity award of 17,746 shares of Common Stock in the form of restricted stock units. The award was granted at no cash cost per share and increases his directly held position to 89,174 shares, including these RSUs, which each represent a contingent right to one share of common stock.

Positive

  • None.

Negative

  • None.
Insider Palmer Eric P
Role null
Type Security Shares Price Value
Grant/Award Common Stock 17,746 $0.00 --
Holdings After Transaction: Common Stock — 89,174 shares (Direct, null)
Footnotes (1)
  1. [object Object]
RSU grant size 17,746 shares Restricted stock units granted to Eric P. Palmer
Post-grant holdings 89,174 shares Total Common Stock held directly after transaction
Grant price per share $0.0000 per share Reported transaction price for RSU award
Transaction date 2026-07-02 Date of RSU grant
restricted stock units ("RSUs") financial
"Includes 17,746 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
contingent right financial
"Each RSU represents a contingent right to receive one share of the Issuer's common stock"
Common Stock financial
"security_title": "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What did LifeStance Health Group (LFST) director Eric P. Palmer report on this Form 4?

Eric P. Palmer reported an equity award of 17,746 shares of LifeStance Health Group Common Stock. The award was granted as restricted stock units at no cash cost per share and represents a compensation-related acquisition, not an open-market purchase or sale.

How many LifeStance Health Group (LFST) shares does Eric P. Palmer hold after this grant?

After the grant, Eric P. Palmer holds 89,174 shares of LifeStance Health Group Common Stock directly. This total includes 17,746 restricted stock units, each of which represents a contingent right to receive one share of the company’s common stock in the future.

What type of transaction was reported by Eric P. Palmer in LFST’s Form 4 filing?

The Form 4 shows a grant or award acquisition coded as “A,” representing 17,746 restricted stock units. This is a compensation-related equity award, not an open-market transaction, and therefore does not reflect a discretionary buy or sell decision in the company’s stock.

What are the restricted stock units (RSUs) reported in the LFST Form 4 filing?

The filing states that 17,746 restricted stock units were granted to Eric P. Palmer. Each RSU represents a contingent right to receive one share of LifeStance Health Group common stock, typically subject to vesting conditions specified in the company’s equity compensation arrangements.

Did Eric P. Palmer buy or sell LifeStance Health Group (LFST) shares on the open market?

No open-market buy or sell occurred in this Form 4. Eric P. Palmer received 17,746 restricted stock units as an equity award at a reported price of $0.0000 per share, indicating a compensation grant rather than a market transaction involving cash consideration.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Palmer Eric P

(Last)(First)(Middle)
C/O LIFESTANCE HEALTH GROUP, INC.
4800 N. SCOTTSDALE ROAD, SUITE 2500

(Street)
SCOTTSDALE ARIZONA 85251

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
LifeStance Health Group, Inc. [ LFST ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/02/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/02/2026A17,746(1)A$0.0089,174D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Includes 17,746 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
By: /s/ Ryan Pardo, Attorney-in-Fact07/07/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)